Elraglusib is aimed at treating pancreatic ductal adenocarcinoma. Credit: Jo Panuwat D/Shutterstock. Actuate Therapeutics has gained orphan medicinal product designation (OMPD) from the European ...

Actuate Therapeutics (ACTU) announced that the European Medicines Agency, EMA, has granted Orphan Medicinal Product Designation, OMPD, to elraglusib, a novel GSK-3beta inhibitor, for the treatment ...

Shares of Jai Corp. tumbled nearly 20% on Thursday after an industrial land parcel of over 5,286 acres was sold to Reliance Industries Ltd. at a valuation of Rs 2,200 crore. Urban Infrastructure ...

Before joining MarketTools, Mr. Strauss was General Counsel at public enterprise software companies Actuate Corporation and Brio Software, as well as Corporate Counsel at Adobe Systems.

As a BDC, Ares Capital makes loans to middle-market companies, which generate between $10 million and $250 million in annual earnings before interest, taxes, depreciation, and amortization (EBITDA ...

OpenAI said it would be restructured as a public benefit corporation, and that the nonprofit that controls the organization would receive shares in the new company. By Cade Metz Cade Metz has ...

SYDNEY, Dec 23 (Reuters) - News Corp has agreed to sell its Australian cable-TV unit Foxtel to British-owned sports network DAZN for A$3.4 billion ($2.1 billion) including debt, cutting the ...

Sony Group Corporation has signed a strategic capital and business alliance agreement with Kadokawa Corporation to conduct a third-party allotment on January 7, 2025 to acquire 12,054,100 new ...

US-based biopharma, Actuate Therapeutics’s elraglusib reduced the risk of death by 37% in a Phase I/II metastatic pancreatic cancer trial. The randomised Phase I/II trial (NCT03678883 ...